About Us

ADispell is a technology development company focused on creating solutions that that leverage our unique findings and proprietary compounds for drug addiction, dementia and other neurodegenerative disorders.

The company business model starts with licensing-in technology then performing the early and middle stage pharmaceutical development work. We will then consider options that include licensing the technology or continuing direct development clinical trials to a marketable product.

We are happy to provide updates to our progress and successes. Please send an email to info@adispell.com section and provide your contact information.

ADispell is based in Rochester, NY with operations also in Ithaca, NY.